Mark S. Schmidt

Nature Communications · 2016

⊕ Open access · CC-BY

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

▲ 714

Cell Reports · 2019

⊕ Open access · CC-BY

Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures

▲ 446

Nature Metabolism · 2020

⊕ Preprint · OA

Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages

▲ 414

Cell Metabolism · 2018

⊕ Open access · OA

Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice

▲ 331

Science Advances · 2023

⊕ Open access · CC-BY

Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study

▲ 130

GeroScience · 2023

⊕ Preprint · OA

A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment

▲ 42

The EMBO Journal · 2024

⊕ Open access · CC-BY

Control of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function

▲ 32

Hepatology Communications · 2020

⊕ Open access · CC-BY

Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease

▲ 27

bioRxiv (Cold Spring Harbor Laboratory) · 2019

⊕ Preprint · CC-BY

Nicotinamide riboside augments the human skeletal muscle NAD ⁺ metabolome and induces transcriptomic and anti-inflammatory signatures in aged subjects: a placebo-controlled, randomized trial

▲ 11

bioRxiv (Cold Spring Harbor Laboratory) · 2021

⊕ Preprint · CC-BY

Nicotinamide riboside alleviates Parkinson’s disease symptoms but downregulates dopamine metabolism upon lactacystin-induced proteostasis failure

▲ 3